bullish
Indegene Limited Pre-IPO: Subscribe on Profitable Niche Business Model and Attractive Valuation
Tina has highlighted this Insight as a Top Pick
1k Views29 Apr 2024 07:23
SUMMARY
- Indegene Limited (1864095D IN) has set IPO price band at INR430–452 per share. The IPO consists of fresh issue as well as OFS by existing shareholders.
- Considering FY24 annualized post-IPO EPS of INR13.48, Indegene seeks a P/E valuation of 31.9–33.5x.
- Considering niche business focus, proven execution capability, marquee clientele, long-standing client relationship, life science focus, and comprehensive offering, Indegene’s valuation seems quite attractive.
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »Loading
Top Unpaywalled Insights
More »Loading
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Indegene Lockup Expiry - US$1bn+ Lockup Release, Some Could Look to Book 3x Gain30 Oct 2024
- Indegene IPO Trading - High Anchor Quality + Strong Demand, Expect a Pop on Debut10 May 2024
- Indegene IPO - Marquee Clients, Strong Track Record, Decent Valuation03 May 2024
- Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth19 Apr 2023
- Indegene Limited (1864095D IN) Pre-IPO: Enough Head Room For Long-Term Profitable Growth13 Apr 2023
- Indegene Pre-IPO Tearsheet22 Dec 2022
x